Treatment of experimental allergic encephalomyelitis by selective removal of CD4+ T cells.
Experimental allergic encephalomyelitis (EAE) is a major animal model of human multiple sclerosis (MS). The pathogenesis of both MS and EAE directly involves CD4+ helper T cells. To remove CD4+ T cells selectively from the circulation, we designed a new column in which anti-CD4 monoclonal antibody was immobilized on the activated substance. Most of the CD4+ T cells, including pathogenic T cells, were selectively adsorbed from whole blood with a direct perfusion through the column in vitro, resulting in depletion of the antigen-specific T cell responses. A preliminary trial of ex vivo treatment with the column in EAE rats lowered the percentages of CD4+ populations but failed to alter the course of the disease, suggesting repeated treatment would be necessary to suppress the development of the disease. We conclude that this new column is potentially useful, and repeated treatment would be beneficial in MS and other CD4+ T cell dependent autoimmune diseases.
Matsuo
H
H
Department of Neurology, Kawatana National Hospital, Nagasaki, Japan.
Ichinose
K
K
Ohtsuru
I
I
Fujishita
S
S
Onodera
H
H
Suematsu
J
J
Yoshida
M
M
Yamawaki
N
N
Shibuya
N
N
D000818:Animals; D000911:Antibodies, Monoclonal; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000628:therapy*; D005260:Female; D007163:Immunosorbent Techniques; D051381:Rats; D011917:Rats, Inbred Lew
D000911:Antibodies, Monoclonal